Diane van der Woude

6.3k total citations · 1 hit paper
85 papers, 4.1k citations indexed

About

Diane van der Woude is a scholar working on Rheumatology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Diane van der Woude has authored 85 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Rheumatology, 50 papers in Radiology, Nuclear Medicine and Imaging and 23 papers in Immunology. Recurrent topics in Diane van der Woude's work include Rheumatoid Arthritis Research and Therapies (51 papers), Monoclonal and Polyclonal Antibodies Research (50 papers) and Systemic Lupus Erythematosus Research (48 papers). Diane van der Woude is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (51 papers), Monoclonal and Polyclonal Antibodies Research (50 papers) and Systemic Lupus Erythematosus Research (48 papers). Diane van der Woude collaborates with scholars based in Netherlands, Sweden and United States. Diane van der Woude's co-authors include T. Huizinga, Annette H M van der Helm–van Mil, René E. M. Toes, Leendert A. Trouw, Andreea Ioan‐Facsinay, V. Derksen, Hans Ulrich Scherer, M. P. M. van der Linden, Rachel Knevel and Karim Raza and has published in prestigious journals such as Nature Communications, The Journal of Immunology and Scientific Reports.

In The Last Decade

Diane van der Woude

83 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Update on the epidemiology, risk factors, and disease outcomes of rheumatoid arthritis

2018 327 citations Diane van der Woude, Annette H M van der Helm–van Mil Best Practice & Research Clinical Rheumatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Diane van der Woude Netherlands	32	2.8k	1.4k	1.1k	606	463	85	4.1k
Carla A. Wijbrandts Netherlands	30	1.7k 0.6×	619 0.5×	1.1k 1.0×	443 0.7×	461 1.0×	47	2.9k
Olivier Vittecoq France	36	2.0k 0.7×	462 0.3×	776 0.7×	581 1.0×	547 1.2×	165	3.5k
Anca Askanase United States	27	2.4k 0.9×	771 0.6×	1.6k 1.5×	250 0.4×	233 0.5×	135	3.3k
Maarten C. Kraan Netherlands	33	2.5k 0.9×	480 0.4×	1.2k 1.1×	937 1.5×	705 1.5×	53	4.1k
Cheryl Yarboro United States	31	3.3k 1.2×	848 0.6×	2.6k 2.4×	495 0.8×	596 1.3×	51	5.3k
Josef S. Smolen Austria	24	2.9k 1.0×	893 0.7×	1.2k 1.1×	1.7k 2.8×	966 2.1×	37	5.3k
John J. Cush United States	31	2.5k 0.9×	418 0.3×	1.6k 1.5×	529 0.9×	1.2k 2.5×	59	4.3k
Arnaud Constantin France	30	1.9k 0.7×	269 0.2×	829 0.8×	427 0.7×	605 1.3×	120	3.1k
Andrea Rubbert‐Roth Germany	33	3.3k 1.2×	576 0.4×	1.7k 1.5×	480 0.8×	1.5k 3.2×	123	5.1k
Hans‐Peter Tony Germany	32	1.6k 0.6×	685 0.5×	2.1k 1.9×	438 0.7×	803 1.7×	151	4.4k

Countries citing papers authored by Diane van der Woude

Since Specialization

Citations

This map shows the geographic impact of Diane van der Woude's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diane van der Woude with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diane van der Woude more than expected).

Fields of papers citing papers by Diane van der Woude

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diane van der Woude. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diane van der Woude. The network helps show where Diane van der Woude may publish in the future.

Co-authorship network of co-authors of Diane van der Woude

This figure shows the co-authorship network connecting the top 25 collaborators of Diane van der Woude. A scholar is included among the top collaborators of Diane van der Woude based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diane van der Woude. Diane van der Woude is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kissel, Theresa, Diane van der Woude, Karin A. van Schie, et al.. (2025). Anti-myeloperoxidase IgM B cells in anti-neutrophil cytoplasmic antibody-associated vasculitis. Nature Communications. 16(1). 1582–1582. 2 indexed citations

Morton, Fraser, Annemarie L Dorjée, Duncan Porter, et al.. (2025). Smoking as a risk factor for rheumatoid arthritis: predominant association with IgA autoantibodies – comprehensive analysis of anti-modified protein antibodies with smoking and genetic risk factors in rheumatoid arthritis. Arthritis Research & Therapy. 27(1). 101–101. 3 indexed citations

Derksen, Ninotska I. L., Joep Killestein, Abraham Rutgers, et al.. (2025). Elevated Fab glycosylation of autoantibodies maintained during B cell depletion therapy. Scientific Reports. 15(1). 14770–14770. 1 indexed citations

Volkov, Mikhail, Joanneke C. Kwekkeboom, Arnoud de Ru, et al.. (2024). Acetylated bacterial proteins as potent antigens inducing an anti-modified protein antibody response. RMD Open. 10(3). e004411–e004411. 1 indexed citations

Kissel, Theresa, V. Derksen, Arthur E. H. Bentlage, et al.. (2024). N-linked Fc glycosylation is not required for IgG-B-cell receptor function in a GC-derived B-cell line. Nature Communications. 15(1). 393–393. 4 indexed citations

Bacon, Andrew, Nivine Levarht, Peter A. van Veelen, et al.. (2024). POS0369 IN RHEUMATOID ARTHRITIS, IgA AUTOANTIBODIES ARE PRESENT IN A POLYMERIC STATE; CLUES FOR A MUCOSAL ORIGIN OF THE AUTOIMMUNE RESPONSE?. Annals of the Rheumatic Diseases. 83. 305–305. 1 indexed citations

Woude, Diane van der, et al.. (2023). The impact of reclassification by the 2022 ACR/EULAR classification criteria on risk factors for relapse in patients with ANCA-associated vasculitis. Clinical Kidney Journal. 16(12). 2754–2756. 1 indexed citations

Volkov, Mikhail, Maximilian Brinkhaus, Karin A. van Schie, et al.. (2023). IgG Fab Glycans Hinder FcRn-Mediated Placental Transport. The Journal of Immunology. 210(2). 158–167. 16 indexed citations

Kissel, Theresa, Lise Hafkenscheid, Mami Tamai, et al.. (2022). IgG Anti–Citrullinated Protein Antibody Variable Domain Glycosylation Increases Before the Onset of Rheumatoid Arthritis and Stabilizes Thereafter: A Cross‐Sectional Study Encompassing ~1,500 Samples. Arthritis & Rheumatology. 74(7). 1147–1158. 35 indexed citations

10.

Scherer, Hans Ulrich, Diane van der Woude, & René E. M. Toes. (2022). From risk to chronicity: evolution of autoreactive B cell and antibody responses in rheumatoid arthritis. Nature Reviews Rheumatology. 18(7). 371–383. 57 indexed citations

11.

Moel, Emma C. de, L. Heimans, Jan‐Åke Nilsson, et al.. (2020). Association Between Bone Mineral Density and Autoantibodies in Patients With Rheumatoid Arthritis. Arthritis & Rheumatology. 73(6). 921–930. 23 indexed citations

12.

Moel, Emma C. de, V. Derksen, Leendert A. Trouw, et al.. (2019). In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment response. Arthritis Research & Therapy. 21(1). 28–28. 45 indexed citations

13.

Moel, Emma C. de, Jürgen Rech, Michael Mähler, et al.. (2019). Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs. Arthritis Research & Therapy. 21(1). 268–268. 18 indexed citations

14.

Volkov, Mikhail, Annemarie L Dorjée, Lise Hafkenscheid, et al.. (2019). Different classes of anti-modified protein antibodies are induced on exposure to antigens expressing only one type of modification. Annals of the Rheumatic Diseases. 78(7). 908–916. 40 indexed citations

15.

Moel, Emma C. de, Elisa A. Rozeman, Ellen Kapiteijn, et al.. (2018). Autoantibody Development under Treatment with Immune-Checkpoint Inhibitors. Cancer Immunology Research. 7(1). 6–11. 129 indexed citations

16.

Woude, Diane van der & Annette H M van der Helm–van Mil. (2018). Update on the epidemiology, risk factors, and disease outcomes of rheumatoid arthritis. Best Practice & Research Clinical Rheumatology. 32(2). 174–187. 327 indexed citations breakdown →

17.

Cabezas, José M. Montero, Hein Putter, T. Huizinga, et al.. (2017). Long-term mortality in patients with ST-segment elevation myocardial infarction is associated with anti-citrullinated protein antibodies. International Journal of Cardiology. 240. 20–24. 12 indexed citations

18.

Suwannalai, Parawee, Hans Ulrich Scherer, Diane van der Woude, et al.. (2010). Anti-citrullinated protein antibodies have a low avidity compared with antibodies against recall antigens. Annals of the Rheumatic Diseases. 70(2). 373–379. 64 indexed citations

19.

Woude, Diane van der, Solbritt Rantapää‐Dahlqvist, A. Ioan-Facsinay, et al.. (2010). Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis. Annals of the Rheumatic Diseases. 69(8). 1554–1561. 249 indexed citations

20.

Greenwald, Rebecca J., Alexander J. McAdam, Diane van der Woude, Abhay R. Satoskar, & Arlene H. Sharpe. (2002). Cutting Edge: Inducible Costimulator Protein Regulates Both Th1 and Th2 Responses to Cutaneous Leishmaniasis. The Journal of Immunology. 168(3). 991–995. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact